Grundläggande statistik
| CIK | 1416172 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Nexeon Medsystems Inc
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| April 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2021 Nexeon Medsystems, Inc. (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission |
|
| April 9, 2021 |
Agreement to Rescind Contract of Sale Exhibit 10.1 OTC:NXNN AGREEMENT TO RESCIND CONTRACT OF SALE This Agreement to Rescind Contract of Sale (the ?Agreement?) is a made and effective 4/8/2021 BETWEEN: Rosellini Scientific Holdings, LLC (the "Seller"), a corporation organized and existing under the laws of Nevis with its head office located at: 10 Jews Street, Ramsbury Site, Charlestown, Nevis AND: Mina Mar Corporation (the "Purchaser" |
|
| April 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-55655 Nexeon Medsystems, Inc. (Exact name of registrant as specified in |
|
| November 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2020 Nexeon Medsystems, Inc. (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commiss |
|
| April 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28th, 2019 Nexeon Medsystems, Inc. (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commiss |
|
| March 29, 2019 |
NXNN / Nexeon Medsystems Inc NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0001416172 CUSIP NUMBER NOTIFICATION OF LATE FILING 65342G104 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| February 8, 2019 |
NXNN / Nexeon Medsystems Inc WITHDRAWAL OF REGISTRATION STATEMENT ON FORM S-1 February 8, 2019 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| January 15, 2019 |
NXNN / Nexeon Medsystems Inc / Rosellini Family Irrv Tr 2 - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) Rosellini Family Irrv Tr 2 425 Carr 693 St. 1 PMB 220 Dorado, PR 00646 Phone: 817-574-7033 (Name, Address and Telephone Number of Person Authorize |
|
| January 9, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) William Rosellini 1910 Pacific Avenue Suite 20000 Dallas, Texas 75201 Telephone: (844) 919-9990 (Name, Address and Telephone Number of Person |
|
| January 9, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) Jamie Tunnell Harris 425 PMB 693 ST 1 Dorado, PR 00646 Phone: 817-602-1480 (Name, Address and Telephone Number of Person Authori |
|
| December 24, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) Jamie Tunnell Harris 425 PMB 693 ST 1 Dorado, PR 00646 Phone: 817-602-1480 (Name, Address and Telephone Number of Person Authorized to Receive Not |
|
| December 17, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 9 TO FORM S-1 ‘As filed with the Securities and Exchange Commission on December 17, 2018 Registration No. |
|
| December 12, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT TO FORM S-1 As filed with the Securities and Exchange Commission on December 12, 2018 Registration No. |
|
| December 12, 2018 |
Exhibit 4.04 FORM OF SPECIMEN UNIT CERTIFICATE NUMBER U- UNITS SEE REVERSE FOR CERTAIN DEFINITIONS NEXEON MEDSYSTEMS INC UNITS CONSISTING OF ONE SHARE OF COMMON STOCK AND TWO WARRANTS TO EACH PURCHASE ONE SHARE OF COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one (1) share of common stock, par value $0.001 per share (“Common Stock”), of NEXEON MEDSYSTEMS IN |
|
| December 12, 2018 |
Form of Underwriting Agreement Exhibit 1.01 NEXEON MEDSYSTEMS INC. Units Each Unit Consisting of One Share of Common Stock and Two Warrants to Purchase One Share of Common Stock Each UNDERWRITING AGREEMENT , 2018 ThinkEquity, a division of Fordham Financial Management, Inc. As representative of the several Underwriters Named in Schedule VI hereto 17 State Street, 22nd Floor New York, NY 10004 Ladies and Gentlemen: Nexeon Medsys |
|
| December 12, 2018 |
Form of Warrant Agency Agreement by and between the Company and Equity Stock Transfer Exhibit 4.03 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of , 2018 (the “Issuance Date”) between Nexeon Medsystems Inc, a company incorporated under the laws of the State of Nevada (the “Company”), and Equity Stock Transfer, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), dated , 20 |
|
| December 11, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission F |
|
| December 11, 2018 |
Exhibit 99.1 Nexeon MedSystems Inc. Corporate Overview www.nexeonmed.com Nexeon MedSystems Inc Corporate Overview www.nexeonmed.com PRIVATE AND CONFIDENTIAL NEXEON MEDSYSTEMS INC www.nexeonmed.com Safe Harbor Statement 2 This presentation contains forward - looking statements and projections. The company makes no express or implied representation or warranty as to the completeness of this informat |
|
| December 7, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 7 TO FORM S-1 ‘As filed with the Securities and Exchange Commission on December 7, 2018 Registration No. |
|
| December 7, 2018 |
Employment Agreement, dated December 7, 2018, between the Company and William Rosellini Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of December 7, 2018 (the “Effective Date”), by and between Nexeon Medsystems Inc, a corporation organized under the laws of Nevada (the “Company”) and William Rosellini (“Executive” and together with the Company, the “Parties”). R E C I T A L S The Company has special expertise in its business |
|
| December 7, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 30, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 6 TO FORM S-1 As filed with the Securities and Exchange Commission on November 29, 2018 Registration No. |
|
| November 20, 2018 |
Exhibit 10.1 Execution Version SENIOR SECURED CONVERTIBLE PROMISSORY NOTE FIRST AMENDMENT This FIRST AMENDMENT TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTE (the “Amendment”), dated as of November 20, 2018, is entered into by NEXEON MEDSYSTEMS INC, a Nevada corporation (hereinafter called the “Borrower”), and LEONITE CAPITAL, LLC, a Delaware limited liability company, or registered assigns (the “H |
|
| November 20, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission F |
|
| November 19, 2018 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission F |
|
| November 19, 2018 |
Nexeon MedSystems Announces Third Quarter 2018 Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nexeon MedSystems Announces Third Quarter 2018 Financial Results Dallas, TX November 19, 2018 - Nexeon MedSystems Inc (”Nexeon”) (OTCQB: NXNN), a neurostimulation medical device company, announced today financial results for the third quarter of 2018. Operational Highlights: ● Manufacturing revenues for the quarter were $1.9 million, an increase of 138% compared |
|
| November 19, 2018 |
NXNN / Nexeon Medsystems Inc / Rosellini William - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) William Rosellini 1910 Pacific Avenue Suite 20000 Dallas, T |
|
| November 19, 2018 |
NXNN / Nexeon Medsystems Inc QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 NEXEON MEDSYSTEMS INC (Ex |
|
| November 14, 2018 |
NXNN / Nexeon Medsystems Inc NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0001416172 NOTIFICATION OF LATE FILING CUSIP NUMBER 65342G104 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ T |
|
| November 5, 2018 |
Exhibit 99.1 Nexeon MedSystems Inc. Corporate Overview www.nexeonmed.com Nexeon MedSystems Inc. Corporate Overview www.nexeonmed.com PRIVATE AND CONFIDENTIAL NEXEON MEDSYSTEMS INC. www.nexeonmed.com Safe Harbor Statement 2 This presentation contains forward - looking statements and projections. The company makes no express or implied representation or warranty as to the completeness of this inform |
|
| November 5, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 1, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2018 Nexeon MedSystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 29, 2018 |
Letter to Securities and Exchange Commission from Paritz & Company, P.A., dated _______________ Exhibit 16.1 October 29, 2018 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements made by Nexeon Medsystems, Inc. under Item 4.01 of its Form 8-K dated October 29, 2018. We agree with the statements concerning our Firm in such Form 8-K. Very truly yours /s/ Paritz & Company, PA |
|
| October 29, 2018 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2018 Nexeon MedSystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission Fi |
|
| September 26, 2018 |
Joint Filing Agreement with Rosellini Scientific Holdings, LLC Exhibit 99.1 AGREEMENT TO FILE JOINT SCHEDULE 13D Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby consent to the joint filing on their behalf of a single Schedule 13D and any amendments thereto, with respect to the beneficial ownership by each of the undersigned of shares of the common stock of NEXEON MEDSYSTEMS INC, a Nevada corporation. |
|
| September 26, 2018 |
NXNN / Nexeon Medsystems Inc / Rosellini William - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) William Rosellini 1910 Pacific Avenue Suite 20000 Dallas, T |
|
| August 13, 2018 |
NXNN / Nexeon Medsystems Inc QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 NEXEON MEDSYSTEMS INC (Exact n |
|
| July 24, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 5 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on July 24, 2018 Registration No. |
|
| July 20, 2018 |
NEXEON MEDSYSTEMS Inc. Warrant To Purchase Common Stock Exhibit 4.04 PURSUANT TO THE TERMS OF SECTION 1 OF THIS WARRANT, ALL OR A PORTION OF THIS WARRANT MAY HAVE BEEN EXERCISED, AND THEREFORE THE ACTUAL NUMBER OF WARRANT SHARES REPRESENTED BY THIS WARRANT MAY BE LESS THAN THE AMOUNT SET FORTH ON THE FACE HEREOF. NEXEON MEDSYSTEMS Inc. Warrant To Purchase Common Stock Warrant No.: Number of Shares of Common Stock: Date of Issuance: , 2018 (“Issuance Da |
|
| July 20, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 4 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on July 20, 2018 Registration No. |
|
| July 20, 2018 |
Exhibit 1.01 NEXEON MEDSYSTEMS inc. Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT July , 2018 National Securities Corporation As representative of the several Underwriters Named in Schedule VI hereto 200 Vesey Street 25th Floor New York, NY 10281 Ladies and Gentlemen: Nexeon Medsystems Inc., a Nevada corporation |
|
| July 20, 2018 |
NEXEON MEDSYSTEMS Inc. Warrant To Purchase Common Stock Exhibit 4.03 PURSUANT TO THE TERMS OF SECTION 1 OF THIS WARRANT, ALL OR A PORTION OF THIS WARRANT MAY HAVE BEEN EXERCISED, AND THEREFORE THE ACTUAL NUMBER OF WARRANT SHARES REPRESENTED BY THIS WARRANT MAY BE LESS THAN THE AMOUNT SET FORTH ON THE FACE HEREOF. NEXEON MEDSYSTEMS Inc. Warrant To Purchase Common Stock Warrant No.: Number of Shares of Common Stock: Date of Issuance: , 2018 (“Issuance Da |
|
| July 19, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 3 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on July 19, 2018 Registration No. |
|
| July 19, 2018 |
Form of Underwriting Agreement Exhibit 1.01 NEXEON MEDSYSTEMS inc. Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase One Half Share of Common Stock UNDERWRITING AGREEMENT July , 2018 National Securities Corporation As representative of the several Underwriters Named in Schedule VI hereto 200 Vesey Street 25th Floor New York, NY 10281 Ladies and Gentlemen: Nexeon Medsystems Inc., a Nevada corpor |
|
| July 19, 2018 |
Opinion of Sichenzia Ross Ference Kesner LLP, as to the legality of securities being registered Exhibit 5.01 July 19, 2018 VIA ELECTRONIC TRANSMISSION Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Nexeon Medsystems Inc, Form S-1 Registration Statement (File No. 333-224715) Ladies and Gentlemen: We refer to the above-captioned registration statement on Form S-1 (the “Registration Statement”) under the Securities Act of 1933, as amended (the “Act”), filed by Ne |
|
| July 13, 2018 |
NXNN / Nexeon Medsystems Inc / Rosellini William - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 65342G 203 (CUSIP Number) William Rosellini 1910 Pacific Avenue Suite 20000 Dallas, T |
|
| July 13, 2018 |
Joint Filing Agreement with Rosellini Scientific Holdings, LLC Exhibit 99.1 AGREEMENT TO FILE JOINT SCHEDULE 13D Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby consent to the joint filing on their behalf of a single Schedule 13D and any amendments thereto, with respect to the beneficial ownership by each of the undersigned of shares of the common stock of NEXEON MEDSYSTEMS INC, a Nevada corporation. |
|
| July 10, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission File N |
|
| July 10, 2018 |
Exhibit 3.06 STATE OF NEVADA BARBARA K. CEGAVSKE Secretory of State KIMBERLEY PERONDI Deputy Secretory for Commercial Recordings OFFICE OF THE SECRETARY OF STATE Certified Copy June 25, 2018 Job Number: C20180625-2373 Reference Number: Expedite: Through Date: The undersigned filing officer hereby certifies that the attached copies are true and exact copies of all requested statements and related s |
|
| July 10, 2018 |
NXNN / Nexeon Medsystems Inc S-1/A As filed with the Securities and Exchange Commission on July 10, 2018 Registration No. |
|
| July 9, 2018 |
Nexeon Medsystems Inc. presentation Exhibit 99.1 |
|
| July 9, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission File N |
|
| June 28, 2018 |
Certificate of Amendment to Articles of Incorporation dated June 25, 2018 Exhibit 3.1 STATE OF NEVADA BARBARA K. CEGAVSKE Secretary of State KIMBERLEY PERONDI Deputy Secretary for Commercial Recordings OFFICE OF THE SECRETARY OF STATE Certified Copy June 25, 2018 Job Number: C20180625-2373 Reference Number: Expedite: Through Date: The undersigned filing officer hereby certifies that the attached copies are true and exact copies of all requested statements and related su |
|
| June 28, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission File |
|
| June 7, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 1 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on June 7, 2018 Registration No. |
|
| June 1, 2018 |
NXNN / Nexeon Medsystems Inc DEFINITIVE INFORMATION STATEMENT DEF 14C 1 def14c0618nexeonmed.htm DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for use of the Commission only as permitted by Rule 14c-6(e)(2) ☒ Definitive Infor |
|
| May 21, 2018 |
NXNN / Nexeon Medsystems Inc PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for use of the Commission only as permitted by Rule 14c-6(e)(2) ☐ Definitive Information Statement nexeon medsystems inc (Name of Registrant as Speci |
|
| May 21, 2018 |
NXNN / Nexeon Medsystems Inc QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 NEXEON MEDSYSTEMS INC (Exact |
|
| May 17, 2018 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 15, 2018 |
NXNN / Nexeon Medsystems Inc NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response. 2.50 SEC FILE NUMBER 0001416172 CUSIP NUMBER 65342G104 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, |
|
| May 7, 2018 |
S-1 1 fs12018nexeonmedsystems.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 7, 2018 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEXEON MEDSYSTEMS INC. (Exact name of registrant as specified in its charter) Nevada 3845 81-0756622 (State or other |
|
| May 3, 2018 |
NXNN / Nexeon Medsystems Inc AMENDMENT NO. 1 TO ANNUAL REPORT (Annual Report) 10-K/A 1 f10k2017a1nexeonmedsystems.htm AMENDMENT NO. 1 TO ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the t |
|
| April 30, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission File |
|
| April 30, 2018 |
Exhibit 99.1 Nexeon MedSystems Inc. Corporate Overview www.nexeonmed.com Nexeon MedSystems Inc. Corporate Overview www.nexeonmed.com PRIVATE AND CONFIDENTIAL NEXEON MEDSYSTEMS INC. www.nexeonmed.com Safe Harbor Statement 2 This presentation contains forward - looking statements and projections. The company makes no express or implied representation or warranty as to the completeness of this inform |
|
| April 24, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2018 Nexeon Medsystems Inc (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commission File |
|
| April 5, 2018 |
Exhibit 10.28 Execution Version STOCK PURCHASE AGREEMENT by and between HENRI DECLOUX AND PAUL MACORS as sellers and NEXEON MEDSYSTEMS BELGIUM S.P.R.L. as buyer APRIL 7, 2017 SPA Decloux/Macors – Nexeon Page 1 Execution Version This STOCK Purchase Agreement (this “Agreement”) is entered into on or about April 7, 2017, by and between Henri Decloux, an individual with Belgian nationality, residing i |
|
| April 5, 2018 |
Share Loan Agreement between Michael Rosellini and Nexeon MedSystems Inc, dated December 29, 2017 Exhibit 10.35 SHARE LOAN AGREEMENT SHARE LOAN AGREEMENT (the "Agreement"), dated as of December 29, 2017, (the "Effective Date), is entered into by and between Michael Rosellini an individual, with a primary address of 12147 LUEDERS LANE, (“Lender”), and Nexeon MedSystems Inc, a Nevada Corporation (the "Borrower"), located at 1910 Pacific Avenue, Suite 20000, Dallas, TX 75201, hereinafter collecti |
|
| April 5, 2018 |
Exhibit 10.31 CBC Banque Branch LIEGE - CENTRE EF CB2629 - BOULEVARD PIERCOT 35 - 4000 LIEGE- BELGIQUE copy for the borrowers Standardised summary information document CKZ C13-6683555-84 Credit application 001 While we do our utmost to ensure this summary document accurately reflects the main provisions of your credit contract, the contract will prevail in the event of any discrepancies between th |
|
| April 5, 2018 |
Exhibit 10.34 DEBT REPAYMENT AGREEMENT DEBT REPAYMENT AGREEMENT (the “Agreement”), dated as of December 29, 2017, (the “Effective Date), is entered into by and between Rosellini Scientific, LLC, a Texas Limited Liability Company (“Lender”), and Nexeon Medsystems Belgium, SPRL, A Belgium Limited Private Company, (the “Borrower”), located at Rue Bois Saint-Jean 15/1, 4102 Seraing (Liege), Belgium, h |
|
| April 5, 2018 |
Exhibit 10.36 WAIVER OF DEBT AGREEMENT Between the undersigned: Nexeon Medsystems Belgium SPRL, a Belgian company duly incorporated and validly existing under Belgian law, with registered office at Rue du Bois St- Jean 15, ,4102 Seraing, and registered in the register of legal persons with number BE 0525.673.682, represented according its bylaws by: a) Hamilton Emily - 77 Calle Reef, Dorado, Puert |
|
| April 5, 2018 |
KBC Commercial Finance Invoice Discounting Agreement, dated September 29, 2017 Exhibit 10.32 KBC Commercial Finance Invoice Discounting Agreement The undersigned: 1. the naamloze vennootschap (company with limited liability) KBC Commercial Finance with its registered office at Havenlaan 6, 1080 Brussels, Belgium, company number: RLP VAT BE 0403.278.488, and recognised by the Royal Decree of 10 April 1964, published in the Belgian Official Gazette of 27 May 1964. represented |
|
| April 5, 2018 |
Form Services Agreement between Medi-Line, S.A. and H.D. Resources, S.P.R.L., dated April 7, 2017 Exhibit 10.29 Execution Version FORM SERVICES AGREEMENT by and between MEDI-LINE S.A. as Company and HD RESOURCES S.P.R.L. as Manager APRIL 7, 2017 Services Agreement Medi-Line – HD Resources Page 1 Execution Version This services agreement (the “Agreement”) is made and entered into on April 7, 2017 and, subject to article 1.2 below, effective as of May 31, 2017 (the “Effective Date”). BETWEEN (1) |
|
| April 5, 2018 |
Exhibit 21.1 SUBSIDIARIES Nexeon MedSystems Inc, a Nevada corporation, had the U.S. and international subsidiaries shown below as of December 31, 2017. Nexeon MedSystems Inc is not a subsidiary of any other entity. Name of Subsidiary Jursidiction of Organization U.S. Subsidiaries: Nexeon Medsystems Puerto Rico Operations Company Corporation Puerto Rico Pulsus Medical, LLC Kentucky International Su |
|
| April 5, 2018 |
NXNN / Nexeon Medsystems Inc ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 NEXEON MEDSYSTEMS INC (Exact name |
|
| April 5, 2018 |
Exhibit 10.33 CBC Banque Branch LIEGE - CENTRE EF CB2629 - BOULEVAR.D PIERCOT 35 - 4000 LIEGE - BELGIQUE Credit contract CKZ 729-1405073-45 Credit application 009 MEDI-LINE NV at 4031 ANGLEUR, R. D.GARDES-FRONTIERE, established on 18-02-1994, entered in the Register of Legal Persons under number VAT BE 0452.084.633, hereinafter referred to as 'the borrowers', even if there is only one, and the soc |
|
| April 5, 2018 |
Exhibit 10.30 CBC Banque Branch LIEGE - CENTRE EF CB2629 - BOULEVARD PIERCOT 35 - 4000 LIEGE - BELGIQUE Credit contract CKZ 729-140073-45 Credit Application 007 MEDI-LINE NV at 4031 ANGLEUR, R. D.GARDES-FRONTIERE, established on 18-02-1994, entered in the Register of Legal Persons under number VAT BE 0452.084.633, hereinafter referred to as ‘the borrowers’, even if there is only one, and the naaml |
|
| April 2, 2018 |
NXNN / Nexeon Medsystems Inc NOTIFICATION OF LATE FILING OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response. 2.50 FORM 12b-25 SEC FILE NUMBER 0001416172 CUSIP NUMBER NOTIFICATION OF LATE FILING 65342G104 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31 |
|
| December 12, 2017 |
NEXEON MEDSYSTEMS INC INTRODUCTION TO PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS Exhibit 99.3 NEXEON MEDSYSTEMS INC INTRODUCTION TO PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS (Unaudited) The following unaudited pro forma condensed combined financial statements give effect to the of acquisition on Nexeon Medsytems Belgium, SPRL (?NMB?) by Nexeon MedSystems Inc (?the Company?). completed as of September 1, 2017 (the ?Acquisition Date?). On September 1, 2017, Nexeon MedSys |
|
| December 12, 2017 |
FINANCIAL STATEMENTS OF BUSINESS ACQUIRED DECEMBER 31, 2016 and 2015 Exhibit 99.1 FINANCIAL STATEMENTS OF BUSINESS ACQUIRED DECEMBER 31, 2016 and 2015 FINANCIAL STATEMENTS Page No. Report of Independent Registered Public Accounting Firm 2 Balance Sheet as of December 31, 2016 and 2015 3 Statements of Comprehensive Income for the years ended December 31, 2016 and 2015 4 Statements of Stockholders? Equity (Deficit) for the years ended December 31, 2016 and 2015 5 Sta |
|
| December 12, 2017 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 1, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Emp |
|
| December 12, 2017 |
FINANCIAL STATEMENTS OF BUSINESS ACQUIRED (unaudited) as of JUNE 30, 2017 Exhibit 99.2 FINANCIAL STATEMENTS OF BUSINESS ACQUIRED (unaudited) as of JUNE 30, 2017 FINANCIAL STATEMENTS Page No. Balance Sheets as of June 30, 2017 and December 31, 2016 2 Statements of Comprehensive Income for the three and six months ended June 30, 2017 and 2016 3 Statements of Cash Flows for the six months ended June 30, 2017 and 2016 4 Notes to the financial statements 5 NEXEON MEDSYSTEMS |
|
| November 20, 2017 |
NXNN / Nexeon Medsystems Inc QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 NEXEON MEDSYSTEM |
|
| November 13, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER CUSIP NUMBER (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2017 ? Transition Report on Form 10-K ? |
|
| November 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2017 Nexeon Medsystems, Inc. (Exact name of registrant as specified in its charter) Nevada 000-55655 81-0756622 (State or other jurisdiction of incorporation) (Commiss |
|
| October 6, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini Michael - AMENDMENT #1 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address a |
|
| October 6, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini Michael - AMENDMENT #3 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address a |
|
| October 6, 2017 |
SC 13G/A 1 p1232a2-13g.htm AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 8 |
|
| October 4, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini Elizabeth - AMENDMENT #1 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address a |
|
| September 27, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini William - AMENDMENT #3 TO SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Na |
|
| September 27, 2017 |
EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value per share, of Nexeon MedSystems Inc, a Nevada corporation, and further agree that this Joint Fil |
|
| September 27, 2017 |
EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value per share, of Nexeon MedSystems Inc, a Nevada corporation, and further agree that this Joint Fil |
|
| September 27, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini William - AMENDMENT #4 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address a |
|
| September 18, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for use of the Commission only as permitted by Rule 14c-6(e)(2) ☑ Definitive Information Statement nexeon medsystems inc (Name of Registrant as Speci |
|
| September 5, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 1, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Emplo |
|
| September 5, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for use of the Commission only as permitted by Rule 14c-6(e)(2) ? Definitive Information Statement nexeon medsystems inc (Name of Registrant as Speci |
|
| September 5, 2017 |
Nexeon Medsystems “OTCQB: NXNN” Acquires Belgian Manufacturer EXHIBIT 99.1 Nexeon Medsystems ?OTCQB: NXNN? Acquires Belgian Manufacturer Press Release Additional capacity will support Company?s current commercial product manufacturing needs Liege, Belgium ?Nexeon MedSystems (?Nexeon? or ?the Company?; OTCQB: NXNN) announced today that it has exercised its option to acquire Nexeon Medsystems Belgium, SPRL (?NMB?). This Belgian-based company has been operating |
|
| August 25, 2017 |
Five-Year Warrant issued to Leonite Capital LLC, dated August 24, 2017 (filed as Exhibit 10.4) EXHIBIT 10.4 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| August 25, 2017 |
Exhibit 10.9 DEED OF TRUST 352002.1 PAGE 1 OF 10 NOTICE OF CONFIDENTIALITY RIGHTS: IF YOU ARE A NATURAL PERSON, YOU MAY REMOVE OR STRIKE ANY OR ALL OF THE FOLLOWING INFORMATION FROM ANY INSTRUMENT THAT TRANSFERS AN INTEREST IN REAL PROPERTY BEFORE IT IS FILED FOR RECORD IN THE PUBLIC RECORDS: YOUR SOCIAL SECURITY NUMBER OR YOUR DRIVER?S LICENSE NUMBER. DEED OF TRUST Terms Date: August , 2017 Grant |
|
| August 25, 2017 |
EXHIBIT 10.6 SHARE PLEDGE AGREEMENT in respect of the shares in Nexeon Medsystems Belgium SPRL between Rosellini Scientific LLC Nexeon Medsystems Europe S.?.r.l. as Pledgor and Leonite Capital LLC as Pledgee Date: August 18, 2017 i TABLE OF CONTENTS 1. DEFINITIONS - INTERPRETATION 2 1.1 Definitions 2 1.2 Interpretation 3 2. PLEDGE 5 2.1 Creation of pledge 5 2.2 Undertaking to pledge 5 2.3 Form 5 3 |
|
| August 25, 2017 |
EXHIBIT 10.1 NEXEON MEDSYSTEMS INC SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the ?Agreement?) is made as of August 21, 2017 (the ?Effective Date?) by and between Nexeon Medsystems Inc, a Nevada corporation (the ?Company?), and Leonite Capital LLC, a Delaware limited liability company (the ?Purchaser). Recital To provide the Company with additional resources to conduct its b |
|
| August 25, 2017 |
EXHIBIT 10.2 THIS NOTE HAS BEEN ISSUED WITH ?ORIGINAL ISSUE DISCOUNT? FOR U.S. FEDERAL INCOME TAX PURPOSES. THE ISSUER WILL MAKE AVAILABLE TO ANY HOLDER OF THIS NOTE: (1) THE ISSUE PRICE AND ISSUE DATE OF THE NOTE, (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE, (3) THE YIELD TO MATURITY OF THE NOTE, AND (4) ANY OTHER INFORMATION REQUIRED TO BE MADE AVAILABLE BY U.S. TREASURY REGULATIONS UP |
|
| August 25, 2017 |
EXHIBIT 10.5 SECURITY AND PLEDGE AGREEMENT This SECURITY AND PLEDGE AGREEMENT (the ?Agreement?) is made and entered into on August 21, 2017, by and among NEXEON MEDSYSTEMS INC, a Nevada corporation (the ?Debtor?), the other parties identified as ?Obligors? on the signature pages hereto and such other parties that may become Obligors hereunder after the date hereof (together with the Debtor, indivi |
|
| August 25, 2017 |
Two-Year Warrant issued to Leonite Capital LLC, dated August 24, 2017 (filed as Exhibit 10.3) EXHIBIT 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| August 25, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 24, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Employe |
|
| August 25, 2017 |
Personal Guaranty of Randy Michael Rosellini, dated August 18, 2017 (filed as Exhibit 10.7) EXHIBIT 10.7 PERSONAL GUARANTY THIS PERSONAL GUARANTY (?Guaranty?), dated as of August 18, 2017, is made by Randy Michael Rosellini, an individual (the ?Guarantor?), in favor of Leonite Capital, LLC, a Delaware limited liability company (the ?Lender?) (together with the Guarantor, the ?Parties?). W I T N E S S E T H: WHEREAS, Lender is making a loan (the ?Loan?) to NEXEON MEDSYSTEMS INC, a Nevada |
|
| August 25, 2017 |
Warrant issued to Randy M. Rosellini, dated August 24, 2017 (filed as Exhibit 10.8) EX-10.8 9 ex108.htm EXHIBIT 10.8 EXHIBIT 10.8 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD E |
|
| August 11, 2017 |
NXNN / Nexeon Medsystems Inc 10-Q (Quarterly Report) 10-Q 1 nm8817010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 |
|
| June 28, 2017 |
EXHIBIT 10.1 1708 Jaggie Fox Way, Lexington, KY 40511 May 24, 2017 CONFIDENTIAL Dear Daniel Powell, On behalf of Nexeon MedSystems Inc, (the ?Company? or ?Nexeon?) we are very pleased to offer you the position of Vice President, Sales and Marketing. This position reports to the Company President and Chief Commercial Officer, Brian Blischak. Your start date with Nexeon will be June 26th, 2017. You |
|
| June 28, 2017 |
EXHIBIT 10.2 EMPLOYEE CONFIDENTIALITY AGREEMENT This Agreement is entered into as of May 24, 2017 by and between Nexeon MedSystems Inc (?Company?), a Nevada corporation with its principal address at 1708 Jaggie Fox Way, Lexington, KY 40511 and Daniel Powell (?Employee?). Company and Employee are referred to collectively as ?Parties and individually as a ?Party?. WHEREAS, the Company wishes to hire |
|
| June 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Employer |
|
| June 28, 2017 |
Option Agreement between the Company and Daniel Powell, dated June 26, 2017 (filed as Exhibit 10.3) EXHIBIT 10.3 NEXEON MEDSYSTEMS INC 2016 Omnibus Incentive Plan Stock Option Award Agreement Nexeon MedSystems Inc (the ?Company?), pursuant to its 2016 Omnibus Incentive Plan (the ?Plan?), hereby grants an Option to purchase shares of the Company?s common stock to you, the Participant named below. The terms and conditions of the Option Award are set forth in this Agreement, consisting of this cove |
|
| June 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for use of the Commission only as permitted by Rule 14c-6(e)(2) ? Definitive Information Statement nexeon medsystems inc (Name of Registrant as Speci |
|
| June 7, 2017 |
424B3 1 j65170424b3.htm Filed pursuant to Rule 424(b)(3) Registration No. 333-217535 Prospectus 5,332,496 Shares of Common Stock We are registering an aggregate of 5,332,496 shares of common stock, $0.001 par value per share (the “Common Stock”) (collectively, the “Resale Shares”) of Nexeon MedSystems Inc (referred to herein as “we”, “us”, “our”, “Nexeon”, “Registrant”, or the “Company”) for resal |
|
| June 5, 2017 |
NEXEON MEDSYSTEMS INC. 1708 Jaggie Fox Way Lexington, Kentucky June 5, 2017 NEXEON MEDSYSTEMS INC. 1708 Jaggie Fox Way Lexington, Kentucky June 5, 2017 TRANSMITTED VIA EDGAR United States Securities and Exchange Commission Office of Electronics and Machinery 100 F Street NE Washington, DC 20549 Attention: Amanda Ravitz, Assistant Director Re: Nexeon MedSystems Inc (the “Company”) Registration Statement on Form S-1 (the “Registration Statement”) Filed April 28, 2017 Amendm |
|
| June 5, 2017 |
As filed with the Securities and Exchange Commission on June 5, 2017 Table of Contents As filed with the Securities and Exchange Commission on June 5, 2017 Registration No. |
|
| May 9, 2017 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55655 NEXEON MEDSYSTEMS IN |
|
| April 28, 2017 |
As filed with the Securities and Exchange Commission on April 28, 2017 Table of Contents As filed with the Securities and Exchange Commission on April 28, 2017 Registration No. |
|
| March 29, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 29, 2017 |
SUBSIDIARIES NEXEON MEDSYSTEMS INC, A NEVADA CORPORATION EXHIBIT 21.1 SUBSIDIARIES OF NEXEON MEDSYSTEMS INC, A NEVADA CORPORATION Entity Jurisdiction of Incorporation or Organization % Ownership Nexeon Medsystems Europe, SARL a Luxembourg private limited liability company 100% Nexeon Medsystems Puerto Rico Operating Company Corporation a Puerto Rico Stock Corporation 100% Pulsus Medical LLC a Kentucky limited liability company 100% The Company currently |
|
| March 10, 2017 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Emplo |
|
| March 10, 2017 |
PROFESSIONAL RELATIONS AND CONSULTING AGREEMENT EXHIBIT 10.1 PROFESSIONAL RELATIONS AND CONSULTING AGREEMENT THIS PROFESSIONAL RELATIONS AND CONSULTING AGREEMENT (the ?Agreement?) is between NEXEON MEDSYSTEMS INC, a Nevada corporation, (the ?Company?) whose address is 1708 Jaggie Fox Way, Lexington, Kentucky 40511 and ACORN MANAGEMENT PARTNERS, L.L.C., a Georgia Limited Liability Company located at 4080 McGinnis Ferry Rd #1101, Alpharetta, GA 3 |
|
| February 28, 2017 |
EXHIBIT 10.2 Director Services Agreement Director Services Agreement made as of January 1, 2017 by and between Nexeon MedSystems Inc, a Nevada Corporation, (hereinafter the ?Company?) and Kent J. George with an address of 700 Virginia Street, Suite 400, South Charleston, West Virginia 25304 (hereinafter ?Director?). Introduction. The Company is a Nevada corporation with Bylaws that provide for a B |
|
| February 28, 2017 |
EX-10.1 2 p0234ex10-1.htm EXECUTIVE EMPLOYMENT CONTRACT EXHIBIT 10.1 Nexeon MedSystems Inc Executive Employment Contract This Executive Employment Contract (the “Agreement”) entered into on the 1st day of January, 2017 (the “Effective Date”) between Emily Hamilton, MD, an individual, (“Executive”), and Nexeon MedSystems Inc, a Nevada corporation (“Company”), having its principal place of business |
|
| February 28, 2017 |
EXHIBIT 10.3 Director Services Agreement Director Services Agreement made as of January 1, 2017 by and between Nexeon MedSystems Inc, a Nevada Corporation, (hereinafter the ?Company?) and Michael Neitzel with an address of 6006 Yorkville Court, Dallas, Texas 75248 (hereinafter ?Director?). Introduction. The Company is a Nevada corporation with Bylaws that provide for a Board of Directors to be ele |
|
| February 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 1, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Employe |
|
| February 3, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address an |
|
| January 19, 2017 |
Financial Statements and Exhibits, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Employe |
|
| January 19, 2017 |
EX-10.1 2 p0123ex10-1.htm STOCK EXCHANGE AGREEMENT EXHIBIT 10.1 STOCK EXCHANGE AGREEMENT THIS STOCK EXCHANGE AGREEMENT (the "Agreement"), dated as of January 6, 2017, (the "Effective Date), is entered into by and between Nexeon MedSystems Inc (“Nexeon”), a Nevada corporation located at 1708 Jaggie Fox Way, Lexington, Kentucky 40511, and Rosellini Scientific LLC, a Texas limited liability company ( |
|
| January 17, 2017 |
EX-10.2 3 p0117ex10-2.htm LOAN AGREEMENT EXHIBIT 10.2 loan agreement This loan agreement (the “Agreement”) made as of 10th January 2017 by and between: (i) Nexeon Medsystems Europe, S.à r.l., a private limited liability company (société à responsabilité limitée), having its registered office at 33, rue du Puits Romain, L-8070 Bertrange, Grand Duchy of Luxembourg, registered with the Luxembourg Tra |
|
| January 17, 2017 |
Financial Statements and Exhibits, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2017 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Employ |
|
| January 17, 2017 |
Promissory Note dated January 10, 2017 (filed as Exhibit 10.3) EXHIBIT 10.3 PROMISSORY NOTE EUR 1,000,000 (One million Euros) 10th January 2017 FOR VALUE RECEIVED, the undersigned Nexeon Medsystems Belgium S.p.r.l., a company incorporated under the laws of Belgium, having its registered office at Rue du Bois St-Jean 15/1 4102 Seraing, registered with the Belgian Companies Register (BCE) under number 0525.673.682 (the "Maker"), hereby unconditionally promises |
|
| January 17, 2017 |
EXHIBIT 10.4 Security AGREEMENT dated as of JANUARY 10, 2017 by and between Nexeon Medsystems Belgium S.p.r.l as Borrower and Grantor and NEXEON MEDSYSTEMS EUROPE, S. ? R.L. as Lender and Secured Party 1 Section 1. Definitions, Etc 2 Section 2. Representations and Warranties 5 2.01 Organizational Matters; Enforceability, Etc 6 2.02 Title 6 2.03 Names, Etc 6 2.04 Changes in Circumstances 6 2.05 Pro |
|
| January 17, 2017 |
EXHIBIT 10.1 ACQUISITION AGREEMENT This acquisition agreement (the ?Acquisition Agreement?) is entered into as of the 10th day of January 2017 and is effective as of the 2nd day of January, 2017 (the ?Effective Date?), BY AND BETWEEN (1) Rosellini Scientific, LLC, a limited liability company formed under the laws of the State of Texas, United States of America, having its registered office at 2820 |
|
| January 9, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini William - AMENDMENT #2 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 10 (CUSIP Number) Micheal K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address an |
|
| January 9, 2017 |
EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value per share, of Nexeon MedSystems Inc, a Nevada corporation, and further agree that this Joint Fil |
|
| January 9, 2017 |
EX-99.1 2 p0922a1ex99-1.htm JOINT FILING AGREEMENT EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value per share, of Nexeon MedSystems Inc, a Nevada |
|
| January 9, 2017 |
NXNN / Nexeon Medsystems Inc / Rosellini William - AMENDMENT #1 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 10 (CUSIP Number) Micheal K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address an |
|
| December 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 20, 2016 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Emplo |
|
| December 29, 2016 |
EXHIBIT 10.1 NEXEON MEDSYSTEMS INC EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the ?Agreement?) is made and entered into on the 20th day of December, 2016, with an effective date of December 1, 2016, (the ?Effective Date?), by and between Nexeon MedSystems Inc, a Nevada corporation (the ?Company?), having its principal place of business at 1708 Jaggie Fox Way, Lexington, KY 40511 and Brian Bli |
|
| December 29, 2016 |
EXHIBIT 10.2 Executive Employment Contract This Executive Employment Agreement (this “Agreement”) is made this 21st day of December 2016 and effective December 1, 2016 (the “Effective Date”) by and between Nexeon MedSystems Inc., a Nevada Corporation (“Company”) and Christopher R. Miller (“Executive”). Company and Executive are referred to collectively as “Parties and individually as a “Party”. BA |
|
| December 20, 2016 |
EXHIBIT 10.1 PATENT LICENSE ASSET PURCHASE AGREEMENT THIS PATENT LICENSE ASSET PURCHASE AGREEMENT (the ?Agreement?) is made this 15th day of December 2016, (the ?Effective Date?) by and between Nexeon MedSystems Inc. a Nevada corporation, (the ?Company?), and William M. Rosellini, an individual, (?Rosellini?) (collectively the ?Parties?). RECITALS WHEREAS, Rosellini currently owns a Patent License |
|
| December 20, 2016 |
Financial Statements and Exhibits, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2016 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Emplo |
|
| December 5, 2016 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2016 NEXEON MEDSYSTEMS INC (Exact Name of Registrant as Specified in Charter) Nevada 000-55655 81-0756622 (State or Other Jurisdiction (Commission File Number) (IRS Employ |
|
| November 21, 2016 |
ATTACHMENT #2 |
|
| November 21, 2016 |
ATTACHMENT #1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
|
| November 21, 2016 |
U.S. Foreign Patents and Patent Applications EXHIBIT 99.1 U.S. Foreign Patents and Patent Applications The patents and intellectual property acquired refers to the patents acquired for development of the micro-perforated balloon catheter system for use in treatment of restenosis associated with hemodialysis, in addition to other patents and reflect the patents valued in the third party fair market valuation of the assets acquired. These pate |
|
| November 21, 2016 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 (AMENDMENT NO. 4) GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 Nexeon MedSystems Inc (Exact Name of Registrant in its Charter) Nevada 81-0756622 (State or other Jurisdiction of Incorporation) (IRS Employer Identification No.) 1708 |
|
| November 21, 2016 |
NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 November 21, 2016 NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 November 21, 2016 SUBMITTED VIA EDGAR Tim Buchmiller, Senior Attorney Amanda Ravitz, Assistant Director Office of Electronics and Machinery Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| November 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-5565 |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2016 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report |
|
| October 5, 2016 |
NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 October 5, 2016 NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 October 5, 2016 SUBMITTED VIA EDGAR Tim Buchmiller, Senior Attorney Amanda Ravitz, Assistant Director Office of Electronics and Machinery Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| October 5, 2016 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 (AMENDMENT NO. 3) GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 Nexeon MedSystems Inc (Exact Name of Registrant in its Charter) Nevada 81-0756622 (State or other Jurisdiction of Incorporation) (IRS Employer Identification No.) 1708 |
|
| September 27, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address an |
|
| September 26, 2016 |
NXNN / Nexeon Medsystems Inc / Bates Mark C. - SCHEDULE 13G FOR MARK C. BATES Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address an |
|
| September 22, 2016 |
EX-99.1 2 p0922ex99-1.htm JOINT FILING AGREEMENT EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value per share, of Nexeon MedSystems Inc, a Nevada c |
|
| September 22, 2016 |
Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 10 (CUSIP Number) Micheal K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name |
|
| September 22, 2016 |
NXNN / Nexeon Medsystems Inc / Ballard Ralph - SCHEDULE 13G FOR RALPH BALLARD Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NEXEON MEDSYSTEMS INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 65342G 104 (CUSIP Number) Michael K. Hair, P.C. 7407 East Ironwood Court Scottsdale, Arizona 85258 Phone: 480-443-9657 Fax: 480-443-1908 (Name, Address an |
|
| September 9, 2016 |
NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 September 9, 2016 NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 September 9, 2016 SUBMITTED VIA EDGAR Tim Buchmiller, Senior Attorney Amanda Ravitz, Assistant Director Office of Electronics and Machinery Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| September 9, 2016 |
EXHIBIT 10.01 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this ?Agreement?) is made and entered into this 8th day of February, 2016, by and between Nexeon MedSystems, Inc., a Delaware Corporation (?NXDE?), and Nexeon MedSystems Inc, a Nevada corporation (?NXNV?). Together, NXDE and NXNV are the ?Parties?. Recitals A. NXDE is a corporation duly organized and validly existing und |
|
| September 9, 2016 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 (AMENDMENT NO. 2) GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 Nexeon MedSystems Inc (Exact Name of Registrant in its Charter) Nevada 81-0756622 (State or other Jurisdiction of Incorporation) (IRS Employer Identification No.) 1708 |
|
| August 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 (AMENDMENT NO. 1) GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 Nexeon MedSystems Inc (Exact Name of Registrant in its Charter) Nevada 81-0756622 (State or other Jurisdiction of Incorporation) (IRS Employer Identification No.) 1708 Jaggie Fox Way Lex |
|
| August 16, 2016 |
2016 Omnibus Incentive Plan (filed as Exhibit 4.01) EX-4.01 2 p0631a1ex4-01.htm EXHIBIT 4.01 NEXEON MEDSYSTEMS INC 2016 OMNIBUS INCENTIVE PLAN 1. Purpose. The purpose of the Nexeon MedSystems Inc, (the “Company”) Nexeon 2016 Omnibus Incentive Plan (the “Plan”) is to attract and retain the best available personnel for positions of responsibility with the Company, to provide additional incentives to them and align their interests with those of the Co |
|
| August 16, 2016 |
NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 August 16, 2016 NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 August 16, 2016 SUBMITTED VIA EDGAR Tim Buchmiller Senior Attorney Amanda Ravitz Assistant Director Office of Electronics and Machinery Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| August 16, 2016 |
EXHIBIT 10.01 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this ?Agreement?) is made and entered into this 8th day of February, 2016, by and between Nexeon MedSystems, Inc., a Delaware Corporation (?NXDE?), and Nexeon MedSystems Inc, a Nevada corporation (?NXNV?). Together, NXDE and NXNV are the ?Parties?. Recitals A. NXDE is a corporation duly organized and validly existing und |
|
| August 16, 2016 |
NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 August 16, 2016 NEXEON MEDSYSTEMS INC 1708 Jaggie Fox Way Lexington, KY, 40511 August 16, 2016 SUBMITTED VIA EDGAR Tim Buchmiller Senior Attorney Amanda Ravitz Assistant Director Office of Electronics and Machinery Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| August 16, 2016 |
EXHIBIT 10.01 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this ?Agreement?) is made and entered into this 8th day of February, 2016, by and between Nexeon MedSystems, Inc., a Delaware Corporation (?NXDE?), and Nexeon MedSystems Inc, a Nevada corporation (?NXNV?). Together, NXDE and NXNV are the ?Parties?. Recitals A. NXDE is a corporation duly organized and validly existing und |
|
| July 6, 2016 |
Form of Director Indemnification Agreement (filed as Exhibit 10.07) EXHIBIT 10.07 DIRECTOR INDEMNIFICATION AGREEMENT NEXEON MEDSYSTEMS INC THIS DIRECTOR INDEMNIFICATION AGREEMENT (this ?Agreement?) is made as of , 2016, by and among Nexeon MedSystems Inc, a Nevada corporation (the ?Company?), and , an individual who is a Director of the Company (the ?Indemnitee?). Article I RECITALS: A. The Indemnitee has been elected to serve as a Director of the Company and the |
|
| July 6, 2016 |
2016 Omnibus Incentive Plan - Form of Stock Option Award Agreement (filed as Exhibit 4.02) EXHIBIT 4.02 NEXEON MEDSYSTEMS INC 2016 Omnibus Incentive Plan Stock Option Award Agreement Nexeon MedSystesm Inc (the ?Company?), pursuant to its 2016 Omnibus Incentive Plan (the ?Plan?), hereby grants an Option to purchase shares of the Company?s common stock to you, the Participant named below. The terms and conditions of the Option Award are set forth in this Agreement, consisting of this cove |
|
| July 6, 2016 |
EXHIBIT 10.01 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this ?Agreement?) is made and entered into this 8th day of February, 2016, by and between Nexeon MedSystems, Inc., a Delaware Corporation (?NXDE?), and Nexeon MedSystems Inc, a Nevada corporation (?NXNV?). Together, NXDE and NXNV are the ?Parties?. Recitals A. NXDE is a corporation duly organized and validly existing und |
|
| July 6, 2016 |
EXHIBIT 4.01 NEXEON MEDSYSTEMS INC 2016 OMNIBUS INCENTIVE PLAN 1. Purpose. The purpose of the Nexeon MedSystems Inc, (the ?Company?) Nexeon 2016 Omnibus Incentive Plan (the ?Plan?) is to attract and retain the best available personnel for positions of responsibility with the Company, to provide additional incentives to them and align their interests with those of the Company?s stockholders, and to |
|
| July 6, 2016 |
EXHIBIT 3.01 1 2 3 4 5 6 7 |
|
| July 6, 2016 |
EXHIBIT 99.01 NEXEON PATENT PORTFOLIO NANOTUBE-REINFORCED BALLOONS FOR DELIVERING PATENTS # Patent/App # Title 1 US 8187221 THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS, AND METHODS OF MAKING AND USING SAME 2 US 13/455,919 THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS, AND METHODS OF MAKING AND USING SAME 3 US 13/455,973 THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL |
|
| July 6, 2016 |
EXHIBIT 10.05 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is made and entered into as of June 1, 2016, by and between Nexeon MedSystems, Inc., a corporation organized under the laws of Nevada (the ?Company?) and Melanie McWade ("Executive"). R E C I T A L S The Company has special expertise in its business that has enabled it to provide unique career opportunities for its empl |
|
| July 6, 2016 |
EXHIBIT 3.04 1 2 |
|
| July 6, 2016 |
EXHIBIT 10.02 Contribution Agreement BETWEEN ROSELLINI SCIENTIFIC LLC AND NEXEON MEDSYSTEMS INC. This 2015 Contribution Agreement (the ?Agreement?), dated as of January 2, 2016, by and between Rosellini Scientific LLC, a Texas limited liability company and Belltower Associates LLC, a Delaware limited liability company, a wholly owned subsidiary of Rosellini Scitenific LLC, (collectively the ?Trans |
|
| July 6, 2016 |
By-laws (filed as Exhibit 3.05) EXHIBIT 3.05 BY-LAWS OF NEXEON MEDSYSTEMS INC ARTICLE I Corporate Offices 1. Registered Office. The registered office of 665 Paloma Road, Boulder City, Nevada, c/o David Martin, shall be fixed in the corporation?s Certificate of Incorporation, as the same may be amended from time to time. 2. Other Offices. The corporation?s Board of Directors (the ?Board?) may at any time establish other offices a |
|
| July 6, 2016 |
EXHIBIT 3.02 |
|
| July 6, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 Nexeon MedSystems Inc (Exact Name of Registrant in its Charter) Nevada 81-0756622 (State or other Jurisdiction of Incorporation) (IRS Employer Identification No.) 1708 Jaggie Fox Way Lexington, KY 40511 ( |
|
| July 6, 2016 |
Code of Business Conduct and Ethics EX-14.01 16 p0631ex14-01.htm CODE OF BUSINESS CONDUCT AND ETHICS EXHIBIT 14.01 NEXEON MEDSYSTEMS INC CODE OF BUSINESS CONDUCT AND ETHICS AS ADOPTED BY THE BOARD OF DIRECTORS ON DECEMBER 7, 2015 1 TABLE OF CONTENTS I. Introduction A. General Policy and Procedures B. Company Compliance Officer II. Responsibility to Our People A. Respecting One Another B. Employee Privacy C. Equal Opportunity Employe |
|
| July 6, 2016 |
EXHIBIT 3.03 1 2 3 4 5 6 |
|
| July 6, 2016 |
EXHIBIT 10.03 Contribution Agreement This Contribution Agreement (the ?Agreement?), effective as of January 2, 2016, by and between Elizabeth Rosellini, an individual (?Transferor?) and Nexeon MedSystems Inc, a Nevada corporation (?Transferee?). WHEREAS, Transferor owns shares of Restricted Common Stock of Telemend Medical Inc, and shares of Restricted Common Stock of Nuvinat Medical Inc. and wish |
|
| July 6, 2016 |
Form of Director Indemnification Agreement EXHIBIT 10.06 Nexeon Director Services Agreement Director Services Agreement made as of May 1, 2016 between Nexeon MedSystems Inc, a Nevada Corporation, (hereinafter the ?Company?) and Dr. Mark Bates MD (hereinafter ?Director?). Introduction. The Company is a Nevada corporation with Bylaws that provide for a Board of Directors to be elected by the holders of a majority of the issued and outstandin |
|
| July 6, 2016 |
EXHIBIT 10.04 EXECUTIVE SERVICES AGREEMENT THIS AGREEMENT, made as of January 1, 2016 by and between Ronald Conquest, an individual, (the ?Executive?) and Nexeon MedSystems Inc, a Nevada corporation, (the ?Company?). WHEREAS, the Company wishes to retain the services of Ronald Conquest as its Director and Chief Operating Officer; NOW THEREFORE, In consideration of the mutual covenants set forth in |
